Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tangün

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Thrombosis Et Diathesis Haemorrhagica|June 30, 1971
Platelet aggregation and platelet factor 3 activity in myeloproliferative disordersY Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of platelet function in myeloproliferative disorders. 3. Activation of thrombocyte factor 3 by kaolin and ADP]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Methods used in our laboratory for thrombocyte function and study]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of thrombocyte function in myeloproliferative disorders. I. Defective thrombocyte aggregation by ADP, collagen, noradrenaline and thrombin]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of thrombocyte function in myeloproliferative disorders. II. Kaolin-induced thrombocyte ADP liberation and ADP degradation capacity of thrombocyte poor plasma]Y Tangün
The New England Journal of Medicine|October 20, 1977
More on vincristine in treatment of ITPY Tangün, T Atamer
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Clinical and laboratory findings in 6 cases of Glanzmann's thrombasthenia]S Inceman, Y Tangün
International Journal of Hematology|October 1, 1996
Frequency of factor V Leiden in TurkeyU Ozbek, Y Tangün
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Essential athrombia: study of a new caseS Inceman, Y Tangün
Annals of the New York Academy of Sciences|October 27, 1972
Platelet defects in the myeloproliferative disordersS Inceman, Y Tangün
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Thrombosis Et Diathesis Haemorrhagica|June 30, 1971
Platelet aggregation and platelet factor 3 activity in myeloproliferative disordersY Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of platelet function in myeloproliferative disorders. 3. Activation of thrombocyte factor 3 by kaolin and ADP]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Methods used in our laboratory for thrombocyte function and study]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of thrombocyte function in myeloproliferative disorders. I. Defective thrombocyte aggregation by ADP, collagen, noradrenaline and thrombin]Y Tangün
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Abnormalities of thrombocyte function in myeloproliferative disorders. II. Kaolin-induced thrombocyte ADP liberation and ADP degradation capacity of thrombocyte poor plasma]Y Tangün
The New England Journal of Medicine|October 20, 1977
More on vincristine in treatment of ITPY Tangün, T Atamer
Turk Tip Cemiyeti Mecmuasi|January 1, 1970
[Clinical and laboratory findings in 6 cases of Glanzmann's thrombasthenia]S Inceman, Y Tangün
International Journal of Hematology|October 1, 1996
Frequency of factor V Leiden in TurkeyU Ozbek, Y Tangün
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Essential athrombia: study of a new caseS Inceman, Y Tangün
Annals of the New York Academy of Sciences|October 27, 1972
Platelet defects in the myeloproliferative disordersS Inceman, Y Tangün
Pageof 2